Interim report
Page 1
www.capillarytech.com Capillary Technologies India Limited CIN- L72200KA2012PLC063060 Regd. Office - 360, bearing PID No: 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru, Karnataka 560102 Email: secretarial@capillarytech.com Website: www.capillarytech.com Tel: 080-41225179 Date: November 02, 2026 To, BSE Limited Listing Department Phiroze JeeJeebhoy Towers, Dalal Street Fort, Mumbai -400001 Scrip Code: 544614 To, National Stock Exchange of India Limited Listing Department Exchange Plaza , Bandra Kurla Complex Bandra (East), Mumbai -4000051 Symbol: CAPILLARY Dear Sir/Madam, Subject: Outcome of Board Meeting held on November 02, 2026. Pursuant to Regulations 30, 33 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Board of Directors of Capillary Technologies India Limited (the “Company”), at its meeting held today, i.e., November 02, 2026, has, inter alia, considered and approved the following, based on the recommendation of the Audit Committee: 1. The Unaudited Financial Results (Standalone and Consolidated) of t he Company for the quarter and half year ended September 30, 2026 (“Financial Results”). The Board also took on record the Limited Review Report issued by the Statutory Auditors on the Financial Results. 2. The appointment of M/s. Deloitte Touche Tohmatsu India LLP as the Internal Auditor of the Company, in place of M/s. Protiviti India Member Private Limited, with effect from November 02, 2026. The details required under Regulation 30 of the SEBI Listing Regulations read with the SEBI Master Circular are enclosed as Annexure A. A copy of the Financial Results, along with the Limited Review Report, is enclosed. The Meeting of the board of directors of the Company commenced at 10:00 AM (IST) and concluded at 11:40 AM (IST). Further, in continuation to our earli er intimation dated September 24, 2026, regarding closure of trading window, we wish to inform you that the trading window for dealing in the securities of the Company has been closed from October 01, 2026, and shall re -open after 48 hours from the declaration of the financial results of the Company. This outcome of Board Meeting will also be made available on the website of the Company at: https://www.capillarytech.com/investors/shareholder-information/corporate- announcements/2026-27/ We request you to take the above information on records. Yours faithfully, For Capillary Technologies India Limited Gireddy Bhargavi Reddy Company Secretary and Compliance Officer Membership No. A17091 Place: Bengaluru
Page 2
www.capillarytech.com Capillary Technologies India Limited CIN- L72200KA2012PLC063060 Regd. Office - 360, bearing PID No: 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru, Karnataka 560102 Email: secretarial@capillarytech.com Website: www.capillarytech.com Tel: 080-41225179 Annexure A Change of Internal Auditor Sr. No Details of Events that need to be provided Cessation of M/s. Protiviti India Member Private Limited as Internal Auditor of the Company Appointment of M/s. Deloitte Touche Tohmatsu India LLP as the Internal Auditor of the Company a) Reason for change viz. appointment, / reappointment, resignation, removal, death or otherwise Cessation consequent to th e appointment of M/s. Deloitte Touche Tohmatsu India LLP as Internal Auditor of the Company, pursuant to the decision of the Board, on the recommendation of the Audit Committee, to engage a firm with a global network to cover the expanding scale and international operations of the Company. Appointment as Internal Auditor of the Company, in view of the growing scale and complexity of the Company’s operations, including its overseas subsidiaries, and to further strengthen the Company’s internal control, risk management and governance framework by engaging a firm with a global network and specialised expertise in internal audit b) Date of appointment/reappointment/ cessation (as applicable) & term of Appointment/ reappointment; Date of cessation –November 02, 2026 Date of appointment – November 02, 2026 c) Brief profile (in case of appointment); Not Applicable M/s. Deloitte Touche Tohmatsu India LLP (LLPIN: AAE-8458) is a limited liability partnership registered in India and a member firm of the global Deloitte network, one of the Big Fou professional services firms. The firm provides audit, consulting, risk adv isory and tax services, and has extensive experience in internal audit and internal financial controls for listed companies. d) Disclosure of relationships between directors (in case of appointment of a director). Not Applicable Not Applicable
Page 3
Walker Chandiok & Co LLP 5th Floor, 65/2, Block “A”, Bagmane Tridib, Bagmane Tech Park, CV Raman Nagar, Bengaluru 560093 Karnataka, India T +91 80 4243 0700 F +91 80 4126 1228 Chartered Accountants Offices in Ahmedabad, Bengaluru, Chandigarh, Chennai, Dehradun, Goa, Gurugram, Hyderabad, Indore, Kochi, Kolkata, Mumbai, New Delhi, Noida and Pune Walker Chandiok & Co LLP is registered with limited liability with identification number AAC-2085 and has its registered office at L-41 Connaught Circus, Outer Circle, New Delhi, 110001, India Independent Auditor’s Review Report on the Standalone Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Capillary Technologies India Limited 1. We have reviewed the accompanying statement of standalone unaudited financial results (‘the Statement’) of Capillary Technologies India Limited (‘the Company’) for the quarter ended 30 September 2026 and the year to date results for the period 01 April 2026 to 30 September 2026 , being submitted by the Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (‘Listing Regulations’). Attention is drawn to the fact that the figures for the corresponding quarter ended 30 September 202 5 have been approved by the Company’s Board of Directors, but have not been subjected to audit or review. 2. The Statement, which is the responsibility of the Company’s management and approved by the Company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting (‘Ind AS 34’), prescribed under Section 133 of the Companies Act, 2013 (‘the Act’), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India . A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under Section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Page 4
Chartered Accountants Independent Auditor’s Review Report on the Standalone Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (Cont’d) 4. Based on our review conducted as above nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34, prescribed under Section 133 of the Act, and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in accordance with the requirements of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Walker Chandiok & Co LLP Chartered Accountants Firm Registration No: 001076N/N500013 Aasheesh Arjun Singh Partner Membership No.: 210122 UDIN: 26210122RVYYEY2361 Bengaluru 02 November 2026
Page 5
(All amounts in Indian Rupees (₹) million, except per share data) Year Ended 30-Sept-26 30-Jun-26 30-Sep-25 30-Sept-26 30-Sep-25 31-Mar-26 (Unaudited) (Unaudited) (Unaudited) (Refer note 6) (Unaudited) (Audited) (Audited) Income I Revenue from operations 842.58 642.87 465.32 1,485.45 888.57 2,118.90 II Other income 38.48 46.65 16.30 85.13 20.87 105.78 III Total income (I+II) 881.06 689.52 481.62 1,570.58 909.44 2,224.68 IV Expenses - Professional and consultancy expenses 56.34 65.03 55.04 121.37 112.70 213.89 - Software and server charges 36.69 32.87 23.41 69.56 50.27 110.65 - Employee benefit expense (Refer note 4) 324.49 347.23 280.68 671.72 535.49 1,225.96 - Other expenses (Refer note 5) 50.59 47.19 29.86 97.78 57.34 174.24 Total expenses 468.11 492.32 388.99 960.43 755.80 1,724.74 V 412.95 197.20 92.63 610.15 153.64 499.94 - Depreciation and amortisation expenses 111.66 111.92 110.54 223.58 215.83 434.56 - Finance costs 6.98 7.63 11.74 14.61 18.68 36.48 VI Profit/ (loss) before exceptional items and tax 294.31 77.65 (29.65) 371.96 (80.87) 28.90 VII Exceptional items - - - - - - VIII Profit/ (loss) before tax (VI-VII) 294.31 77.65 (29.65) 371.96 (80.87) 28.90 IX Tax expense/ (credit) - Current tax - - - - - - - Deferred tax - - - - - - Total tax expense - - - - - - X Profit/ (loss) after tax for the period/year (VIII-IX) 294.31 77.65 (29.65) 371.96 (80.87) 28.90 Other Comprehensive income/ (loss) -Re-measurement of defined benefit plan, net of tax (2.74) (0.30) (0.69) (3.04) (1.38) (1.19) XI Other comprehensive (loss)/ income, net of tax (2.74) (0.30) (0.69) (3.04) (1.38) (1.19) XII Total comprehensive income/ (loss) (X+XI) 291.57 77.35 (30.34) 368.92 (82.25) 27.71 Paid-up equity share capital 159.18 158.94 158.81 159.18 158.81 158.81 Other equity 8,073.23 (a) Basic (in ₹ per share) 3.70 0.98 (0.40) 4.68 (1.10) 0.38 (b) Diluted (in ₹ per share) 3.67 0.97 (0.40) 4.64 (1.10) 0.38 * Earnings/ (loss) per share data for the quarters is not annualised. See accompanying notes to the standalone financial results for Capillary Technologies India Limited Aneesh Reddy Boddu Place: Bengaluru Managing Director and CEO Date: 2 November 2026 DIN: 02214511 Half-Year Ended Capillary Technologies India Limited CIN Number - L72200KA2012PLC063060 Registered Office: #360 bearing PID No 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru 560 102, Karnataka, India Phone No. +91 80 4122 5179 Website : www.capillarytech.com E-mail: investorrelations@capillarytech.com Statement of Standalone Unaudited Financial Results for the Quarter and Half-Year Ended 30 September 2026 Profit before finance costs, depreciation, amortization and tax expense (III-IV) (a) Items that will not to be reclassified to the statement of profit or loss: Earnings/ (loss) per equity share (face value ₹ 2 each)* Particulars Quarter Ended Page 1 of 2
Page 6
(All amounts in Indian Rupees (₹) million) As at 30 September 2026 As at 31 March 2026 Unaudited Audited ASSETS Non-current assets (a) Property, plant and equipment 32.16 23.64 (b) Intangible assets 593.31 689.17 (c) Right-of-use assets 14.15 27.99 (d) Financial assets (i) Investments 5,105.34 4,214.08 (ii) Other financial assets 11.84 234.53 (e) Other tax assets 82.69 134.40 (f) Other non-current assets 0.81 0.41 Total non-current assets (A) 5,840.30 5,324.22 Current assets (a) Financial assets (i) Trade receivables 1,193.83 768.31 (ii) Cash and cash equivalents 201.82 104.14 (iii) Bank balances other than (ii) above 1,987.60 3,232.40 (iv) Other financial assets 192.89 69.26 (b) Other current assets 241.57 147.93 Total current assets (B) 3,817.71 4,322.04 Total assets (A+B) 9,658.01 9,646.26 EQUITY AND LIABILITIES Equity (a) Equity share capital 159.18 158.81 (b) Other equity 8,536.72 8,073.23 Total equity (A) 8,695.90 8,232.04 Liabilities Non-current Liabilities (a) Financial liabilities (i) Lease liabilities 2.68 6.06 (b) Provisions 110.50 105.59 Total Non-current Liabilities (B) 113.18 111.65 Current Liabilities (a) Financial liabilities (i) Borrowings 447.21 447.21 (ii) Lease liabilities 12.42 22.91 (iii) Trade payables (a) total outstanding dues of micro enterprises and small enterprises 12.49 9.43 197.23 646.73 (iv) Other financial liabilities 81.33 105.81 (b) Other current liabilities 77.44 51.51 (c) Provisions 20.81 18.97 Total current liabilities (C) 848.93 1,302.57 Total liabilities (B+C) 962.11 1,414.22 Total equity and liabilities (A+B+C) 9,658.01 9,646.26 for Capillary Technologies India Limited Aneesh Reddy Boddu Place: Bengaluru Managing Director and CEO Date: 2 November 2026 DIN: 02214511 Capillary Technologies India Limited CIN Number - L72200KA2012PLC063060 Registered Office: #360 bearing PID No 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru 560 102, Karnataka, India Phone No. +91 80 4122 5179 Website : www.capillarytech.com E-mail: investorrelations@capillarytech.com Statement of Standalone Balance Sheet (b) total outstanding dues of creditors other than micro enterprises and small enterprises Particulars
Page 7
(All amounts in Indian Rupees (₹) million) 30 September 2026 30 September 2025 Unaudited Audited A. Cash flow from operating activities Profit/ (Loss) before tax 371.96 (80.50) Adjustments to reconcile profit before tax to net cash flows Depreciation and amortisation expenses 223.58 215.83 Loss allowances under expected credit loss model - (3.50) Share-based payment expense 53.86 20.89 Liabilities no longer required, written back (0.33) - Unrealized exchange loss/(gain) on foreign currency translations (net) (33.32) 21.61 Interest income on income tax refund (3.94) - Interest income on bank deposit (80.39) (8.60) Interest income on security deposits (0.35) - Finance costs 13.87 16.45 Operating profit before working capital changes 544.94 182.18 Working capital adjustments : (Increase) in trade receivables (392.20) (125.82) (Increase) in other assets and other financial assets (current and non-current) (221.82) (99.92) (Decrease)/Increase in trade payables (446.25) 112.64 Increase in other liabilities 25.93 54.61 (Decrease) in other financial liabilities and Provisions (current and non-current) (20.75) (12.94) Cash (used in)/ generated from operations (510.15) 110.75 Direct taxes paid, net 55.65 (22.18) Net cash (used in)/ generated from operating activities (A) (454.50) 88.57 B. Cash flow from investing activities Purchase of property, plant and equipment including intangible assets (122.40) (193.27) Proceeds from redemption of corporate deposits, net 1,467.49 - Investments in subsidiary (857.88) - Change in other bank balances - (5.63) Interest received on bank deposits 85.24 - Net cash generated from/ (used in) investing activities (B) 572.45 (198.90) C. Cash flow from financing activities Proceeds from issue of share capital, (including security premium) 7.46 - Payment of principal and interest portion of lease liabilities (14.85) (18.76) Proceeds from short-term borrowings (net) (89.28) 37.04 Finance costs paid (12.88) (15.10) Net cash (used in)/ generated from financing activities ( C ) (109.55) 3.18 Net increase/ (decrease) in cash and cash equivalents (A+B+C) 8.40 (107.15) Cash and cash equivalents at the beginning of the period 98.47 107.85 Cash and cash equivalents at the end of the period 106.87 0.70 Components of cash and cash equivalents Balances with banks - On current accounts 201.82 0.70 Less: Bank overdraft (94.95) - Total cash and cash equivalents (net of bank overdraft) 106.87 0.70 for Capillary Technologies India Limited Aneesh Reddy Boddu Place: Bengaluru Managing Director and CEO Date: 2 November 2026 DIN: 02214511 Statement of Standalone Cash Flows Capillary Technologies India Limited CIN Number - L72200KA2012PLC063060 Registered Office: #360 bearing PID No 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru 560 102, Karnataka, India Phone No. +91 80 4122 5179 Website : www.capillarytech.com E-mail: investorrelations@capillarytech.com Half-Year Ended Particulars
Page 8
Capillary Technologies India Limited CIN Number - L72200KA2012PLC063060 Registered Office: #360 bearing PID No 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru 560 102, Karnataka, India Phone No. +91 80 4122 5179 Website : www.capillarytech.com E-mail: investorrelations@capillarytech.com Notes: 1 2 3 4 5 Amounts in ₹ million Amount to be utilised as per prospectus Unutilised as at 30 September 2026 Funding our cloud infrastructure cost 1,430.00 925.84 715.81 610.49 Investment in purchase of computer systems for our business 103.42 92.50 979.85 129.72 3,229.08 1,470.53 1,758.55 6 7 for Capillary Technologies India Limited Aneesh Reddy Boddu Place: Bengaluru Managing Director and CEO Date: 2 November 2026 DIN: 02214511 The unaudited standalone financial results for the quarter and half year ended 30 September 2026 can be viewed on the website of the Company, National Stock Exchange of India Limited ('NSE') and BSE Ltd ('BSE') at www.capillarytech.com, www.nseindia.com and www.bseindia.com respectively. Funding inorganic growth through unidentified acquisitions and general corporate purposes 850.13 Net proceeds (net of IPO expenses) 504.16 Investment in research, designing and development of our products and platform 105.32 10.92 Utilisation up to 30 September 2026 *Of the total IPO expenses, an amount of ₹ 132.76 million adjusted with securities premium as of 30 September 2026 and ₹ Nil for the quarter and half year ended 30 September 2026, ₹ 12.59 million and ₹ 32.36 million for the quarter and year ended 31 March 2026 respectively is charged off to Statement of Profit and Loss. The figures for the quarter ended 30 September 2025 is the balancing figure between the audited figure for the half year ended 30 September 2025 and 30 June 2025. Further , the unaudited results for the quarter ended 30 September 2025 has been prepared based on the information compiled by the management in accordance with IND AS 34 and has not been subject to separate audit or review by the statutory auditors. The unaudited standalone financial results, which are published in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. The above unaudited standalone financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 02 November 2026. The statutory auditors of the Company have performed a limited review of the unaudited standalone financial results for the quarter and half year ended 30 September 2026 and have issued a unmodified review report on these results. The Chief Operating Decision Maker ('CODM') evaluates the performance of the Company based on the single operative segment as cloud based intelligent customer engagement software solutions. Therefore, there is only one reportable segment called CRM services in accordance with the requirement of Ind AS 108 "Operating Segments". On 21 November 2025, the Government of India notified the four Labour Codes - the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working Conditions Code, 2020 - consolidating 29 existing labour laws. The Ministry of Labour & Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations. The Group has considered restructured compensation of its employees with effect from 1 April 2026, and assessed the impact of the changes, consistent with the Labour Codes, draft rules, FAQs and legal opinion. The Company has recorded an amount of ₹ Nil for the quarter and half year ended 30 September 2026, ₹ 2.10 million and ₹ 18.24 million in the standalone statement of profit and loss for the quarter and year ended 31 March 2026 respectively. In FY 25-26, the Company had completed its Initial Public Offering (IPO) comprising a fresh issuance of 5,982,635 equity shares with a face value of ₹ 2 each and Offer for Sale of 9,228,796 Equity Shares of face value of ₹ 2 each. These shares were offered at an issue price of ₹ 549-577 per share, which also included 38,095 equity shares reserved for eligible employees. The Company raised a total of ₹ 8,775.01 million (including ₹ 3,450.00 million with respect to fresh issuance of Equity Shares) and the Company's equity shares were subsequently listed on the BSE Ltd. and National Stock Exchange of India Limited with effect from 21 November 2025. Consequently, the Company received an amount of ₹ 3,229.08 million (net of Company's share of IPO expenses amounting to ₹ 220.92 million*). The net proceeds received pending utilisation as at 30 September 2026 (invested in fixed deposits to the extent of ₹ 1,758.50 million and balance ₹ 0.05 million of balance in monitoring bank account). The Company has utilised an amount of ₹ 1470.53 million as of 30 September 2026. Particulars Page 2 of 2
Page 9
Walker Chandiok & Co LLP 5th Floor, 65/2, Block “A”, Bagmane Tridib, Bagmane Tech Park, CV Raman Nagar, Bengaluru 560093 Karnataka, India T +91 80 4243 0700 F +91 80 4126 1228 Walker Chandiok & Co LLP 5th Floor, 65/2, Block “A”, Bagmane Tridib, Bagmane Tech Park, CV Raman Nagar, Bengaluru 560093 Karnataka, India T +91 80 4243 0700 F +91 80 4126 1228 Chartered Accountants Offices in Ahmedabad, Bengaluru, Chandigarh, Chennai, Dehradun, Goa, Gurugram, Hyderabad, Indore, Kochi, Kolkata, Mumbai, New Delhi, Noida and Pune Walker Chandiok & Co LLP is registered with limited liability with identification number AAC-2085 and has its registered office at L-41 Connaught Circus, Outer Circle, New Delhi, 110001, India Independent Auditor’s Review Report on the Consolidated Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) To the Board of Directors of Capillary Technologies India Limited 1. We have reviewed the accompanying statement of unaudited consolidated financial results (‘the Statement’) of Capillary Technologies India Limited (‘the Holding Company’) and its subsidiaries (the Holding Company and its subsidiaries together referred to as ‘the Group’), (refer Annexure 1 for the list of subsidiaries included in the Statement) for the quarter ended 30 September 2026 and the consolidated year to date results for the period 01 April 2026 to 30_September 2026, being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (‘Listing Regulations’) . Attention is drawn to the fact that the consolidated figures for the corresponding quarter ended 30 September 2025 as reported in the Statement have been approved by the Holding Company’s Board of Directors but have not been subjected to audit or review. 2. This Statement, which is the responsibility of the Holding Company’s management and approved by the Holding Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, Interim Financial Reporting (‘Ind AS 34’), prescribed under Section 133 of the Companies Act, 2013 (‘the Act’), and other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. 3. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity, issued by the Institute of Chartered Accountants of India . A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with the Standards on Auditing specified under Section 143(10) of the Act, and consequently, does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33 (8) of the Listing Regulations, to the extent applicable.
Page 10
Chartered Accountants Independent Auditor’s Review Report on the Consolidated Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) (Cont’d) 4. Based on our review conducted and procedures performed as stated in paragraph 3 above , nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in Ind AS 34, prescribed under Section 133 of the Act, and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in accordance with the requirements of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. 5. The Statement includes the interim financial information of 2 subsidiaries, which have not been reviewed by their auditors, whose interim financial information reflects total assets of ₹ 46.32 million as at 30 September 2026, and total revenues of ₹ 15.60 million and ₹ 23.24 million, net profit after tax of ₹ 1.53 million and ₹ 1.76 million, total comprehensive income of ₹ 2.74 million and ₹ 0.56 million for the quarter ended 30 September 2026 and for the period 01 April 2026 to 30 September 2026 respectively, net cash inflows of ₹ 16.32 million for the period 01 April 2026 to 30_September 2026 as considered in the Statement, and have been furnished to us by the Holding Company’s management. Our conclusion on the Statement, in so far as it relates to the amounts and disclosures included in respect of these subsidiaries, are based solely on such unreviewed interim financial information . According to the information and explanations given to us by the management, these interim financial information are not material to the Group. Our conclusion is not modified in respect of this matter with respect to our reliance on the financial information certified by the Board of Directors. For Walker Chandiok & Co LLP Chartered Accountants Firm Registration No: 001076N/N500013 Aasheesh Arjun Singh Partner Membership No. 210122 UDIN: 26210122LWZJVY5018 Bengaluru 02 November 2026
Page 11
Chartered Accountants Annexure 1 referred to in paragraph 1 of the Independent Auditor’s Review Report on the Consolidated Unaudited Quarterly Financial Results and Year to Date Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) List of subsidiaries included in the Statement S.No. Name of the subsidiary Country of incorporation Relationship 1 Capillary Pte. Ltd Singapore Subsidiary 2 Capillary Technologies FZCO (formerly known as Capillary Technologies DMCC) Dubai, United Arab Emirates Step-down subsidiary 3 Capillary Technologies LLC United States of America Step-down subsidiary 4 Capillary Technologies Inc. United States of America Step-down subsidiary 5 Capillary Technologies Europe Limited United Kingdom Step-down subsidiary 6 Capillary Brierley Inc. United States of America Step-down subsidiary 7 Capillary Technologies (Shanghai) Co. Ltd (dissolved w.e.f 14 September 2026) People's Republic of China Step-down subsidiary 8 PT Capillary Technologies Indonesia Indonesia Step-down subsidiary 9 Capillary Technologies (Malaysia) Sdn.Bhd. Malaysia Step-down subsidiary 10 Kognitiv Solutions Inc. (w.e.f 1 May 2025) Canada Step-down subsidiary 11 Session M Inc. (w.e.f 1 May 2026) United States of America Step-down subsidiary 12 Session M Czech Republic s.r.o (w.e.f 1 May 2026) Czech Republic Step-down subsidiary
Page 12
Year Ended 30-Sept-26 30-Jun-26 30-Sept-25 30-Sept-26 30-Sept-25 31-Mar-26 (Unaudited) (Unaudited) (Unaudited) (Refer note 11) (Unaudited) (Audited) (Audited) Income I Revenue from operations 2,713.55 2,566.44 1,793.25 5,279.99 3,592.18 7,345.99 II Other income 60.59 57.08 21.82 117.67 33.45 137.34 III 2,774.14 2,623.52 1,815.07 5,397.66 3,625.63 7,483.33 IVExpenses - Professional and consultancy expenses 388.45 341.56 276.83 730.01 614.61 1,076.59 - Software and server charges 419.58 450.54 333.15 870.12 638.87 1,292.19 - Employee benefit expense (Refer note 9) 1,341.22 1,198.36 886.29 2,539.58 1,743.39 3,538.58 - Other expenses (Refer note 10) 169.52 173.00 110.52 342.52 230.54 510.12 2,318.77 2,163.46 1,606.79 4,482.23 3,227.41 6,417.48 V 455.37 460.06 208.28 915.43 398.22 1,065.85 - Depreciation and amortisation expenses 244.54 200.42 190.95 444.96 363.70 749.71 - Finance costs 11.39 11.66 17.69 23.05 29.36 54.64 VI 199.44 247.98 (0.36) 447.42 5.16 261.50 VIIExceptional items (Refer note 7 and 8) - 333.86 - 333.86 - (249.60) VIII 199.44 (85.88) (0.36) 113.56 5.16 511.10 IX Tax expense/ (credit) - Current tax 7.35 2.73 3.89 10.08 7.79 45.04 - Deferred tax (27.07) 6.91 (7.13) (20.16) (12.96) (57.82) (19.72) 9.64 (3.24) (10.08) (5.17) (12.78) X 219.16 (95.52) 2.88 123.64 10.33 523.88 XI - - - - - - Tax expense of discontinued operations - - - - - - Profit/(loss) after tax from discontinued operations - - - - - - XIIProfit/ (loss) for the period/ year (X + XI) 219.16 (95.52) 2.88 123.64 10.33 523.88 XIIIOther Comprehensive income (a) Items that will be reclassified to profit or loss: 114.07 28.93 138.07 143.00 197.80 566.97 (b) Items that will not to be reclassified to profit or loss: - Re-measurement losses on defined benefit plan, net of tax (2.74) (0.30) (0.69) (3.04) (1.38) (1.19) 111.33 28.63 137.38 139.96 196.42 565.78 330.49 (66.89) 140.26 263.60 206.75 1,089.66 Paid-up equity share capital 159.18 158.94 158.81 159.18 158.81 158.81 Other equity 10,076.12 2.75 (1.20) 0.04 1.56 0.14 6.94 2.73 (1.20) 0.04 1.54 0.14 6.87 * Earnings/ (Loss) per share data for the quarters is not annualised. See accompanying notes to the consolidated financial results for Capillary Technologies India LimitedAneesh Reddy Boddu Place: Bengaluru Managing Director and CEO Date: 2 November 2026 DIN: 02214511 Half-Year Ended Total income (I+II) Total expenses Profit before finance costs, depreciation, amortization and tax expense (III-IV) Quarter Ended Other comprehensive income, net of tax Profit/(loss) before exceptional items and tax Profit/(loss) before tax (VI-VII) Total tax (credit)/ expense Profit/(loss) after tax (VIII - IX) Profit/(loss) before tax from discontinued operations - Exchange differences on translating financial statements of foreign operations Particulars Capillary Technologies India LimitedCIN Number - L72200KA2012PLC063060 Registered Office: #360 bearing PID No 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru 560 102, Karnataka, India Phone No. +91 80 4122 5179 Website : www.capillarytech.com E-mail: investorrelations@capillarytech.com Statement of Consolidated Unaudited Financial Results for the Quarter and Half-Year Ended 30 September 2026 Total comprehensive income/ (loss) (X + XII)
Page 13
(All amounts in Indian Rupees (₹) million) As at 30 September 2026 As at 31 March 2026 Unaudited Audited ASSETS Non-current assets (a) Property, plant and equipment 77.58 37.78 (b) Goodwill 3,297.99 3,095.76 (c) Other intangible assets 1,483.11 1,385.57 (d) Right-of-use assets 81.90 82.63 (e) Financial assets (i) Investments 120.40 118.27 (ii) Other financial assets 48.40 272.50 (f) Deferred tax assets (net) 1,034.38 16.27 (g) Other tax assets 82.69 134.40 (h) Other non-current assets 495.53 649.38 Total non-current assets (A) 6,721.98 5,792.56 Current assets (a) Financial assets (i) Investments 3,066.00 1,246.23 (ii) Trade receivables 2,399.80 1,808.35 (iii) Cash and cash equivalents 674.60 358.11 (iv) Other bank balances 1,987.60 3,232.40 (v) Other financial assets 84.28 93.16 (b) Other current assets 778.58 471.61 Total current assets (B) 8,990.86 7,209.86 Total assets (A+B) 15,712.84 13,002.42 EQUITY AND LIABILITIES Equity (a) Equity share capital 159.18 158.81 (b) Other equity 10,433.99 10,076.12 Total equity (A) 10,593.17 10,234.93 Liabilities Non-current Liabilities (a) Financial liabilities (i) Lease liabilities 51.56 40.34 (b) Provisions 132.66 125.57 (c) Deferred tax liabilities (net) 91.02 27.37 Total Non-current Liabilities (B) 275.24 193.28 Current Liabilities (a) Financial liabilities (i) Borrowings 447.21 447.21 (ii) Lease liabilities 37.45 48.52 (iii) Trade payables (a) total outstanding dues of micro enterprises and small enterprises 12.49 9.43 888.22 734.41 (iv) Other financial liabilities 391.89 220.55 (b) Other current liabilities 2,992.15 1,038.95 (c) Provisions 31.27 31.06 (d) Current tax liabilities (net) 43.75 44.08 Total current liabilities (C) 4,844.43 2,574.21 Total liabilities (B+C) 5,119.67 2,767.49 Total equity and liabilities (A+B+C) 15,712.84 13,002.42 for Capillary Technologies India Limited Aneesh Reddy Boddu Place: Bengaluru Managing Director and CEO Date: 2 November 2026 DIN: 02214511 Capillary Technologies India Limited CIN Number - L72200KA2012PLC063060 Registered Office: #360 bearing PID No 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru 560 102, Karnataka, India Phone No. +91 80 4122 5179 Website : www.capillarytech.com E-mail: investorrelations@capillarytech.com Statement of Consolidated Balance Sheet (b) total outstanding dues of creditors other than micro enterprises and small enterprises Particulars
Page 14
(All amounts in Indian Rupees (₹) million) 30 September 2026 30 September 2025 Unaudited Audited A. Cash flow from operating activities Profit for the year from continuing operations before exceptional items and tax 113.56 5.16 Adjustments to reconcile profit before tax to net cash flows Depreciation and amortisation expenses 444.96 363.70 Loss allowances under expected credit loss model (16.50) 33.08 Share based payment expense 87.23 34.31 Profit on sale of investments (24.74) (8.70) Interest income on income tax refund (3.94) (3.33) Provision / liabilities no longer required, written back (0.38) (0.93) Unrealised exchange (gain)/ loss on foreign currency transactions (net) (30.69) 9.76 Interest income on bank deposits and security deposit (85.17) (9.95) Finance costs 16.95 22.73 Operating profit before working capital changes 501.28 445.83 Working capital adjustments : Decrease/(Increase) in trade receivables 22.59 (282.64) (Increase)/Decrease in other financial assets and other assets (current and non-current) (97.20) 86.54 Increase in trade payable 185.23 219.23 Increase in provision 4.26 13.72 Increase in other financial and other liabilities (current and non-current) 138.16 90.64 Cash generated from operations 754.32 573.32 Direct taxes paid, net 45.24 (18.72) Net cash generated from operating activities (A) 799.56 554.60 B. Cash flow from investing activities Purchase of property, plant and equipment, intangible assets (173.48) (183.07) (Purchase)/sale of current investment, net (1,798.10) (240.39) Interest income on bank deposits 90.03 9.95 Payment for investment in equity shares - (103.52) Redemption of / (investment in) bank deposits 1,467.96 (8.95) Purchase consideration for acquisition of subsidiaries, net of cash acquired (92.51) (1,447.43) Net cash (used in) investing activities (B) (506.10) (1,973.41) C. Cash flow from financing activities Proceeds from issue of share capital, (including security premium) 7.46 - Proceeds from short-term borrowings (net) (89.28) (133.56) Repayment of principal and interest portion of lease liabilities (34.13) (28.53) Finance costs paid (13.13) (19.01) Net cash generated from financing activities (C) (129.08) (181.10) Net increase/(decrease) in cash and cash equivalents (A+B+C) 164.38 (1,599.91) Cash and cash equivalents at the beginning of the period 352.44 2,140.71 Effect of exchange differences on cash and cash equivalents held in foreign currency 62.83 62.69 Cash and cash equivalents at the end of the period 579.65 603.49 Components of cash and cash equivalents Balances with banks - On current accounts 674.60 603.49 Less: Bank overdraft (94.95) - Total cash and cash equivalents (net of bank overdraft) 579.65 603.49 for Capillary Technologies India Limited Aneesh Reddy Boddu Place: Bengaluru Managing Director and CEO Date: 2 November 2026 DIN: 02214511 Capillary Technologies India Limited CIN Number - L72200KA2012PLC063060 Registered Office: #360 bearing PID No 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru 560 102, Karnataka, India Phone No. +91 80 4122 5179 Website : www.capillarytech.com E-mail: investorrelations@capillarytech.com Statement of Consolidated Cash Flows Half-Year EndedParticulars
Page 15
Capillary Technologies India Limited CIN Number - L72200KA2012PLC063060 Registered Office: #360 bearing PID No 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru 560 102, Karnataka, India Phone No. +91 80 4122 5179 Website : www.capillarytech.com E-mail: investorrelations@capillarytech.com 1 2 3 Name of the entity Ownership % as of 30 September 2026 Capillary Pte Ltd., Singapore 100% 100% Capillary Technologies (Malaysia) Sdn. Bhd., Malaysia 100% PT Capillary Technologies Indonesia, Indonesia 100% 100% Capillary Brierley Inc. (formerly known as Brierley & Partners, Inc.) 100% Capillary Technologies Inc, USA 100% 100% Capillary Technologies (Shanghai) Co. Ltd, China - Kognitiv Solutions Inc., Canada 100% Session M Inc, USA 100% Session M Czech Republic s.r.o 100% 4 5 6 On 24 February 2026, the Group entered into a Stock Purchase Agreement with Mastercard International Inc. for the acquisition of 100% equity interest in Session M Inc. and Session M Czech Republic s.r.o. for a total consideration of US$6.86 million. The acquisition was completed and control was obtained on 1 May 2026. Accordingly, the transaction has been accounted for as a business combination in accordance with Ind AS 103, Business Combinations. In the consolidated financial results for the quarter ended 30 June 2026, the accounting for the business combination was provisional, pending final determination of the acquired working-capital balances, identifiable intangible assets, related deferred taxes and other adjustments contemplated under the agreement. During the period ended 30 September 2026, the Group completed the determination of such balances and finalized the purchase price allocation. Consequently, the provisional amounts recognized as at 30 June 2026 have been retrospectively adjusted from the acquisition date to reflect the finalized acquisition date fair values of the identifiable assets acquired and liabilities assumed, with the corresponding adjustment to goodwill. The consequential impact on amortisation, depreciation and deferred tax from 1 May 2026 has also been recognized. The accounting for the business combination is complete as at 30 September 2026. Step-down subsidiary Step-down subsidiary Capillary Technologies LLC (formerly known as 'Persuade Loyalty LLC'), USA Step-down subsidiary Step-down subsidiary (Dissolved w.e.f 14 Sep 2026) Step-down subsidiary (w.e.f. 1 May 2025) Step-down subsidiary (w.e.f. 1 May 2026) Step-down subsidiary (w.e.f. 1 May 2026) The Chief Operating Decision Maker ('CODM') evaluates the performance of the Group based on the single operative segment as cloud based intelligent customer engagement software solutions. Therefore, there is only one reportable segment called CRM services in accordance with the requirement of Ind AS 108 "Operating Segments". On 31 March 2025, Capillary Technologies LLC, a step-down subsidiary of the Company, entered into a Purchase and Sale Agreement with Loyalty Solutions Holdings US Inc. (LSI) to acquire 100% equity interest in Kognitiv Solutions Inc., a company incorporated in Ontario, Canada which is a wholly owned subsidiary of LSI and to purchase the rights, title and interest of the Intellectual property. As part of the transaction, Capillary Technologies LLC also entered into a separate Asset Purchase Agreement with Kognitiv US LLC (another wholly owned subsidiary of LSI) to acquire customer contracts, customer relationships, and associated receivables. These agreements jointly constitute a business combination in accordance with the principles of Ind AS 103 w.e.f. 1 May 2025 for a consideration of CAD 23.44 million (net of net working capital amounting to CAD 0.56 million). This strategic acquisition is expected to enhance the Company’s loyalty business operations in the United States and establish a presence in the Canada location. Step-down subsidiary Step-down subsidiary Step-down subsidiary Capillary Technologies Europe Limited (formerly known as Brierley Europe Limited) Step-down subsidiary Subsidiary The unaudited consolidated financial results, which are published in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting" (“Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 ("The Act") read with relevant rules issued thereunder and other accounting principles generally accepted in India. The above unaudited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 02 November 2026. The statutory auditors of the Company have performed a limited review of the unaudited consolidated financial results for the quarter and half year ended 30 September 2026 and have issued a unmodified review report on these results. The consolidated unaudited financial results include the financial results/information of the Company and the subsidiaries ("The Group") as below: Relationship with the Company Capillary Technologies FZCO, UAE (formerly known as Capillary Technologies DMCC)
Page 16
Capillary Technologies India Limited CIN Number - L72200KA2012PLC063060 Registered Office: #360 bearing PID No 101, 360, 15th Cross Rd, Sector 4, HSR Layout, Bengaluru 560 102, Karnataka, India Phone No. +91 80 4122 5179 Website : www.capillarytech.com E-mail: investorrelations@capillarytech.com 7 8 9 10 Amounts in ₹ million Amount to be utilised as per prospectus Utilisation upto 30 September 2026 Unutilised as at 30 September 2026 Funding our cloud infrastructure cost 1,430.00 504.16 925.84 Investment in research, designing and development of our products and platform 715.81 105.33 610.48 Investment in purchase of computer systems for our business 103.42 10.91 92.51 979.85 850.13 129.72 3,229.08 1,470.53 1,758.55 11 12 for Capillary Technologies India Limited Aneesh Reddy Boddu Place: Bengaluru Managing Director and CEO Date: 2 November 2026 DIN: 02214511 Net proceeds (net of IPO expenses) *Of the total IPO expenses, an amount of ₹ 132.76 million adjusted with securities premium as of 30 September 2026 and ₹ Nil for the quarter and half year ended 30 September 2026, ₹ 12.59 million and ₹ 32.36 million for the quarter and year ended 31 March 2026 respectively is charged off to Statement of Profit and Loss. The unaudited consolidated financial results for the quarter and half year ended 30 September 2026 can be viewed on the website of the Company, National Stock Exchange of India Limited ('NSE') and BSE Ltd ('BSE') at www.capillarytech.com, www.nseindia.com and www.bseindia.com respectively. Exceptional income: The Group acquired a business in the United States through one of its subsidiaries (refer note 7 above), wherein the Purchase and Sale Agreement ("PSA") included a Churn Indemnity Clause — a contractual assurance by the seller that existing customers of the acquired business would continue their association beyond the acquisition date up to an agreed threshold. However, the seller failed to adhere to this commitment, as customer contract terminations during the post-acquisition period exceeded the agreed threshold, thereby constituting a breach of the said clause. Consequent to this breach, the Group received a compensation of ₹ 249.60 million (CAD 3.88 million) from the seller in accordance with the terms of the PSA which has been reflected in the results for the year ended 31 March 2026. Exceptional expense: During the quarter ended 30 June 2026, a cyber-enabled banking fraud occurred in a step-down subsidiary of the Group incorporated in the Czech Republic, resulting in unauthorised bank transfers from the subsidiary's bank account. Based on information available as at the date of approval of these consolidated unaudited financial results, the effect of these unauthorised transfers aggregated to approximately ₹ 333.86 million (€ 3.04 million). Accordingly, this loss has been recognised as an exceptional item in these consolidated unaudited financial results for the quarter ended 30 June 2026. In relation to these transfers, beneficiary accounts for approximately ₹ 46.69 million (€ 0.43 million) have been frozen by the relevant banking authorities as part of ongoing recovery efforts, subsequent to 30 June 2026. The Group has also notified its insurer and initiated a claim under its crime insurance policy. The matter was reported to the relevant law-enforcement authorities, and an independent forensic investigation was initiated. As at the date of approval of these consolidated unaudited financial results, the investigation has been concluded without any adverse findings. Accordingly, the Group's awaits the recovery from insurance company, if any. The Group will continue to evaluate developments in this matter and will recognise any resulting adjustments or provide additional disclosures in future reporting periods, as appropriate. On 21 November 2025, the Government of India notified the four Labour Codes - the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020, and the Occupational Safety, Health and Working Conditions Code, 2020 - consolidating 29 existing labour laws. The Ministry of Labour & Employment published draft Central Rules and FAQs to enable assessment of the financial impact due to changes in regulations. The Group has considered restructured compensation of its employees with effect from 1 April 2026, and assessed the impact of the changes, consistent with the Labour Codes, draft rules, FAQs and legal opinion. The Group has recorded an amount of ₹ Nil for the quarter ended 30 September 2026, ₹ 2.10 million and ₹ 18.24 million in the consolidated statement of profit and loss for the quarter and year ended 31 March 2026 respectively. In FY 25-26, the Company had completed its Initial Public Offering (IPO) comprising a fresh issuance of 5,982,635 equity shares with a face value of ₹ 2 each and Offer for Sale of 9,228,796 Equity Shares of face value of ₹ 2 each. These shares were offered at an issue price of ₹ 549-577 per share, which also included 38,095 equity shares reserved for eligible employees. The Company raised a total of ₹ 8,775.01 million (including ₹ 3,450.00 million with respect to fresh issuance of Equity Shares) and the Company's equity shares were subsequently listed on the BSE Ltd. and National Stock Exchange of India Limited with effect from 21 November 2025. Consequently, the Company received an amount of ₹ 3,229.08 million (net of Company's share of IPO expenses amounting to ₹ 220.92 million*). The net proceeds received pending utilisation as at 30 September 2026 (invested in fixed deposits to the extent of ₹ 1,758.50 million and balance ₹ 0.05 million of balance in monitoring bank account). The Company has utilised an amount of ₹ 1,470.53 million as of 30 September 2026. Particulars Funding inorganic growth through unidentified acquisitions and general corporate purposes The figures for the quarter ended 30 September 2025 is the balancing figure between the audited figure for the half year ended 30 September 2025 and 30 June 2025. Further , the unaudited results for the quarter ended 30 September 2025 has been prepared based on the information compiled by the management in accordance with IND AS 34 and has not been subject to separate audit or review by the statutory auditors.